WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in INCY — Incyte Corp

CIK 1632972 PLYMOUTH, MN

Position in INCY

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$17,174,606

+$3,404,286 QoQ

Shares Held

151,505

+3.6% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

of 77 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 5.8057489851820065.ToString("F0")% Shared 0.ToString("F0")% None 94.194251014818.ToString("F0")%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. INCY ranks #3 (10.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp This page	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc.	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc.	19,919	$4,875,573

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,174,606	151,505	+3.6%	Shares	Sole	2026-07-15
2026-03-31	$13,770,320	146,306	+14.5%	Shares	Sole	2026-04-08
2025-12-31	$12,620,534	127,777	+19.7%	Shares	Sole	2026-01-08
2025-09-30	$9,056,775	106,789	+28.9%	Shares	Sole	2025-10-29
2025-06-30	$5,641,063	82,835	+3.9%	Shares	Sole	2025-07-10
2025-03-31	$4,827,954	79,735	+66.5%	Shares	Sole	2025-04-16
2024-12-31	$3,307,347	47,884	+315.2%	Shares	Sole	2025-03-17
2024-09-30	$762,331	11,533	+22.8%	Shares	Sole	2024-10-24
2024-06-30	$569,100	9,388	-5.6%	Shares	Sole	2024-07-16
2024-03-31	$566,509	9,944	+13.0%	Shares	Sole	2024-04-15
2023-12-31	$552,426	8,798	+114.1%	Shares	Sole	2024-01-30
2023-09-30	$237,376	4,109	-48.9%	Shares	Sole	2023-11-13
2023-03-31	$581,339	8,044	—	Shares	Sole	2023-04-25
No filing history on record for this holder in this stock.